Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Dissecting tumor metabolic heterogeneity: Telomerase and large cell size metabolically define a sub-population of stem-like, mitochondrial-rich, cancer cells

27 Aug 2015

Abstract excerpt

// Rebecca Lamb 1,2 , Bela Ozsvari 1,2 , Gloria Bonuccelli 1,2 , Duncan L. Smith 3 , Richard G. Pestell 4 , Ubaldo E. Martinez-Outschoorn 4 , Robert B. Clarke 1 , Federica Sotgia 1,2 and Michael P. Lisanti 1,2 1 The Breast Cancer Now Research Unit, Institute of Cancer Sciences, University of Manchester, Manchester, UK 2 The Manchester Centre for Cellular Metabolism (MCCM), Institute of Cancer Sciences, University...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Cancer, Hypoxia, and Metabolism
Share to Metabolism, Diabetes, and Cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26323205
DOI: 10.18632/oncotarget.5260

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Dissecting tumor metabolic heterogeneity: Telomerase and large cell size metabolically define a sub-population of stem-like, mitochondrial-rich, cancer cellsPMID 26323205Read ↗

High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistantSemantic proximity Read ↗

“Energetic” Cancer Stem Cells (e-CSCs): A New Hyper-Metabolic and Proliferative Tumor Cell Phenotype, Driven by Mitochondrial EnergySemantic proximity Read ↗

Mitochondria as new therapeutic targets for eradicating cancer stem cells: Quantitative proteomics and functional validation via MCT1/2 inhibitionSemantic proximity Read ↗

Hallmarks of cancer stem cell metabolismSemantic proximity Read ↗

Mitochondrial mass, a new metabolic biomarker for stem-like cancer cells: Understanding WNT/FGF-driven anabolic signalingSemantic proximity Read ↗

Targeting cancer stem cell propagation with palbociclib, a CDK4/6 inhibitor: Telomerase drives tumor cell heterogeneity.Semantic proximity Read ↗

Metabolic Profiles of Cancer Stem Cells and Normal Stem Cells and Their Therapeutic SignificanceSemantic proximity Read ↗

Heterogeneity of glucose metabolism and uptake identifies distinct cancer cell and cancer stem cell phenotypes.Semantic proximity Read ↗

Cancer Stem Cell-Associated Pathways in the Metabolic Reprogramming of Breast CancerSemantic proximity Read ↗

Cancer Stem Cell Metabolism and Potential Therapeutic TargetsSemantic proximity Read ↗

ALDHHigh Breast Cancer Stem Cells Exhibit a Mesenchymal-Senescent Hybrid Phenotype, with Elevated Metabolic and Migratory Activities.Semantic proximity Read ↗

Targeting cancer stem cells from a metabolic perspectiveSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.